ArticleJournal of Cancer2024

Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer.

Yuntao Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.